Similar Items: Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- A critical appraisal of the clinical pharmacokinetics of isoniazid
- The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
- Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
- The therapeutic importance of isoniazid metabolism in elderly patients
- Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
Author: Folb, Peter I
- Prizidilol : analytical methods and in vitro metabolism by hepatic enzymes
- A study of the antiherpes simplex virus type 1 properties of barringtonia racemosa
- An electrophoretic study of fetal mouse brain proteins after in vivo exposure to phenytoin and disulfiram
- The antimalarial potential of Ugandan traditional medicines : a study of six plants used to treat malaria symptoms
- Determination of the effect of blood testing intervals on bioavailability and bioequivalence assessment of fixed-dose drug combination anti-tuberculosis drugs
- In Vitro tests for immunomodulatory effects of medicinal plants used in the treatment of Malaria in South Africa
Author: McIlleron, Helen
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects
- Pharmacokinetic-Pharmacogenetic-and-Pharmacodynamic Adherence Relationships in Cohort South African HIV Infected Children on Lopinavir-and Nevirapine-Based Regimens
- Population pharmacokinetic models describing drug-drug interactions and variability in HIV infected South Africans on protease inhibitor-based antiretroviral regimens with and without tuberculosis
- Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach